Fesoterodine Fumarate Tablet, Extended Release
Product Images NDC 62332-176

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fesoterodine Fumarate (NDC 62332-176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fesoterodine-4-mg.jpg (Fesoterodine 4 mg)

Label for Fesoterodine Fumarate extended-release tablets, 4 mg strength, with a package containing 30 tablets. The label includes storage instructions, manufacturer information (Alembic Pharmaceuticals Limited, India; Alembic Pharmaceuticals Inc., USA), and a barcode with NDC 62332-175-30. It specifies the product is Rx only and features the Alembic logo.*

FDA Label Image

Fesoterodine-8-mg.jpg (Fesoterodine 8 mg)

Label for Fesoterodine Fumarate Extended-release Tablets, 8 mg strength, oral tablet dosage form. The label shows a package of 30 tablets with NDC 62332-176-30. It includes storage instructions, manufacturer details (Alembic Pharmaceuticals Limited, India; Alembic Pharmaceuticals, Inc., USA), and branding with the Alembic logo. The label also states Rx only and contains a barcode and lot/expiration information area.*

FDA Label Image

Fesoterodine-figure1.jpg (Fesoterodine Figure1)

A line graph titled 'Change in Number of Micturitions per 24 h (Study 1)' showing the mean change from baseline in micturitions over 12 weeks for three groups: placebo, Fesoterodine fumarate 4 mg, and Fesoterodine fumarate 8 mg. The y-axis represents the mean change in number of micturitions per 24 hours, with values decreasing from 0 to -3. The Fesoterodine fumarate 8 mg group shows the greatest reduction in micturitions over time compared to the 4 mg dose and placebo.*

FDA Label Image

Fesoterodine-figure2.jpg (Fesoterodine Figure2)

Line graph titled 'Change in Urge Incontinence Episodes per 24 h (Study 1)' showing mean change from baseline in urge incontinence episodes over 12 weeks. It compares placebo (dotted line with circles), Fesoterodine fumarate 4 mg (dashed line with triangles), and Fesoterodine fumarate 8 mg (solid line with squares). Data points depict a greater reduction in episodes for both Fesoterodine fumarate doses compared to placebo over time.*

FDA Label Image

Fesoterodine-figure3.jpg (Fesoterodine Figure3)

Line graph titled 'Change in Number of Micturitions per 24 h (Study 2)' showing mean change from baseline in number of micturitions over 12 weeks. The graph compares three groups: Placebo, Fesoterodine fumarate 4 mg, and Fesoterodine fumarate 8 mg. The placebo group shows a smaller decrease over time compared to both Fesoterodine fumarate groups, which display similar larger decreases in micturitions per 24 hours.*

FDA Label Image

Fesoterodine-figure4.jpg (Fesoterodine Figure4)

A line graph titled 'Change in Urge Incontinence Episodes per 24 h (Study 2)', showing mean change from baseline in episodes per 24 hours over 12 weeks. It compares three groups: placebo, fesoterodine fumarate 4 mg, and fesoterodine fumarate 8 mg, with respective sample sizes 205, 228, and 218. The graph shows decreasing urge incontinence episodes over time for both fesoterodine doses compared to placebo.*

FDA Label Image

Structure (Fesoterodine Str)

Chemical structure of Fesoterodine Fumarate, showing its molecular arrangement as depicted in the image from the FDA SPL submission.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.